Senior insider sale
EVP and CFO at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$2.92M
5.36K shares
What this filing means
DIER MARDI plans to sell 5.36K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $2.92M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001628280-26-013391
Officer· EVP and CFO
Since Mar 2026
5.36K
Shares to sell
$2.92M
Approx. market value
1.18K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
3/1/2026
1.18KTotal acquired1.18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2026 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 1.18K | — |
| Total | 1.18K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.17K
Market value
$2.41M
12/2/2025
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
1.18K
Market value
$511.1K
3/2/2026
Total
Units
5.36K
Value
$2.92M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/2/2025 | 4.17K | $2.41M | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 1.18K | $511.1K | Nasdaq Stock Market | Planned |
| Total | 5.36K | $2.92M | ||